These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2118418)

  • 1. Mechanisms of cyclophosphamide action on hepatic P-450 expression.
    LeBlanc GA; Waxman DJ
    Cancer Res; 1990 Sep; 50(18):5720-6. PubMed ID: 2118418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platinum anticancer drugs modulate P-450 mRNA levels and differentially alter hepatic drug and steroid hormone metabolism in male and female rats.
    LeBlanc GA; Sundseth SS; Weber GF; Waxman DJ
    Cancer Res; 1992 Feb; 52(3):540-7. PubMed ID: 1732040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
    Chang TK; Waxman DJ
    Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative metabolism of cyclophosphamide: identification of the hepatic monooxygenase catalysts of drug activation.
    Clarke L; Waxman DJ
    Cancer Res; 1989 May; 49(9):2344-50. PubMed ID: 2706622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Female-predominant rat hepatic P-450 forms j (IIE1) and 3 (IIA1) are under hormonal regulatory controls distinct from those of the sex-specific P-450 forms.
    Waxman DJ; Morrissey JJ; LeBlanc GA
    Endocrinology; 1989 Jun; 124(6):2954-66. PubMed ID: 2785912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic P450 expression in hypothyroid rats: differential responsiveness of male-specific P450 forms 2a (IIIA2), 2c (IIC11), and RLM2 (IIA2) to thyroid hormone.
    Ram PA; Waxman DJ
    Mol Endocrinol; 1991 Jan; 5(1):13-20. PubMed ID: 2017188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feminization of rat hepatic P-450 expression by cisplatin. Evidence for perturbations in the hormonal regulation of steroid-metabolizing enzymes.
    LeBlanc GA; Waxman DJ
    J Biol Chem; 1988 Oct; 263(30):15732-9. PubMed ID: 3139676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of microsomal NADPH-cytochrome P-450 reductase and cytochrome P-450IVA1 (P-450LA omega) by dehydroepiandrosterone in rats: a possible peroxisomal proliferator.
    Wu HQ; Masset-Brown J; Tweedie DJ; Milewich L; Frenkel RA; Martin-Wixtrom C; Estabrook RW; Prough RA
    Cancer Res; 1989 May; 49(9):2337-43. PubMed ID: 2523237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) modulates rat liver microsomal cyclophosphamide and ifosphamide activation by suppressing cytochrome P450 2C11 messenger RNA levels.
    Chang TK; Chen H; Waxman DJ
    Drug Metab Dispos; 1994; 22(5):673-9. PubMed ID: 7835216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypophysectomy differentially alters P-450 protein levels and enzyme activities in rat liver: pituitary control of hepatic NADPH cytochrome P-450 reductase.
    Waxman DJ; Morrissey JJ; Leblanc GA
    Mol Pharmacol; 1989 Apr; 35(4):519-25. PubMed ID: 2495435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of constitutive cytochrome P-450 gene expression in livers of rats undergoing an acute phase response to endotoxin.
    Morgan ET
    Mol Pharmacol; 1989 Nov; 36(5):699-707. PubMed ID: 2511427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive inhibition of human liver microsomal cytochrome P450 3A-dependent steroid 6 beta-hydroxylation activity by cyclophosphamide and ifosfamide in vitro.
    Murray M; Butler AM; Stupans I
    J Pharmacol Exp Ther; 1994 Aug; 270(2):645-9. PubMed ID: 8071856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the anticancer dehydrotarplatin on cytochrome P450 and antioxidant enzymes in male rat tissues.
    Nannelli A; Messina A; Marini S; Trasciatti S; Longo V; Gervasi PG
    Arch Toxicol; 2007 Jul; 81(7):479-87. PubMed ID: 17364183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripubertal androgen imprinting of rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase: pretranslational regulation and impact on microsomal drug activation.
    Chang TK; Bellward GD
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1383-91. PubMed ID: 8819526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450.
    Marinello AJ; Bansal SK; Paul B; Koser PL; Love J; Struck RF; Gurtoo HL
    Cancer Res; 1984 Oct; 44(10):4615-21. PubMed ID: 6380709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon down regulates the male-specific cytochrome P450IIIA2 in rat liver.
    Craig PI; Mehta I; Murray M; McDonald D; Aström A; van der Meide PH; Farrell GC
    Mol Pharmacol; 1990 Sep; 38(3):313-8. PubMed ID: 1698250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of liver P450 reductase suppression on cyclophosphamide activation, pharmacokinetics and antitumoral activity in a cytochrome P450-based cancer gene therapy model.
    Huang Z; Raychowdhury MK; Waxman DJ
    Cancer Gene Ther; 2000 Jul; 7(7):1034-42. PubMed ID: 10917206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of testosterone and growth hormone treatment on hepatic microsomal P450 expression in the diabetic rat.
    Thummel KE; Schenkman JB
    Mol Pharmacol; 1990 Jan; 37(1):119-29. PubMed ID: 2105452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo modulation of alternative pathways of P-450-catalyzed cyclophosphamide metabolism: impact on pharmacokinetics and antitumor activity.
    Yu LJ; Drewes P; Gustafsson K; Brain EG; Hecht JE; Waxman DJ
    J Pharmacol Exp Ther; 1999 Mar; 288(3):928-37. PubMed ID: 10027828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of male-specific cytochrome P450 2c and its mRNA by 3,4,5,3',4',5'-hexachlorobiphenyl in rat liver is not causally related to changes in serum testosterone.
    Yeowell HN; Waxman DJ; LeBlanc GA; Linko P; Goldstein JA
    Arch Biochem Biophys; 1989 Jun; 271(2):508-14. PubMed ID: 2499261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.